Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluating the effects of remdesivir in severe COVID-19 in hospitalized patients
IRCT20151227025726N28Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of remdesivir in coronavirus pneumonia, sponsored by Shahid Beheshti University of Medical Sciences. Started Sep 2021; status: completed.
02
Drugs
remdesivir
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20151227025726N28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151227025726N28.